Orbimed Advisors - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2022$7,247,000
+13.2%
435,0000.0%0.14%
+16.4%
Q2 2022$6,403,000
-40.7%
435,0000.0%0.12%
-33.7%
Q1 2022$10,792,000
-22.6%
435,0000.0%0.18%
-2.2%
Q4 2021$13,950,000
-10.9%
435,0000.0%0.18%
+4.1%
Q3 2021$15,651,000
+183.8%
435,000
+248.0%
0.17%
+207.1%
Q2 2021$5,515,000
-3.6%
125,0000.0%0.06%
+5.7%
Q1 2021$5,718,000
-33.7%
125,0000.0%0.05%
-29.3%
Q4 2020$8,628,000125,0000.08%
Other shareholders
PULMONX CORP shareholders Q2 2022
NameSharesValueWeighting ↓
KPCB XIII Associates, LLC 994,971$10,278,0505.54%
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$621,9072.98%
PURA VIDA INVESTMENTS, LLC 726,298$7,502,6581.42%
CFM WEALTH PARTNERS LLC 264,039$2,727,5230.71%
BRAIDWELL LP 988,559$10,211,8140.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,017,958$10,515,5060.23%
Rock Springs Capital Management LP 652,400$6,739,2920.18%
Point72 Asset Management, L.P. 2,929,903$30,265,8980.09%
ALGERT GLOBAL LLC 117,327$1,2120.06%
Campbell & CO Investment Adviser LLC 45,380$468,7750.06%
View complete list of PULMONX CORP shareholders